About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
RAIN
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Rain Oncology reports Q1 results
- Rain Therapeutics GAAP EPS of $0.70
- Rain Oncology resumed with a buy at Roth Capital on liposarcoma candidate milademetan
- Rain Therapeutics to change name to Rain Oncology
- Rain Therapeutics GAAP EPS of -$0.68 in-line
- Rain Therapeutics prices $50M stock offering
- Rain Therapeutics cancer drug shows promise in phase 2 trial
- Rain Therapeutics GAAP EPS of -$0.66 in-line
- Rain Therapeutics GAAP EPS of -$0.66
- Rain Therapeutics GAAP EPS of -$0.68 misses by $0.06
- Rain Therapeutics buys 557,728 shares
- Rain to use Genentech's Tecentriq in testing combination therapy for solid tumors
- Rain Therapeutics to join NASDAQ Biotechnology Index
- Dosing underway in Rain Therapeutics' mid-stage milademetan trial for advanced solid tumors
- Rain Therapeutics EPS misses by $0.19
- Rain Therapeutics EPS beats by $0.15
- Rain Therapeutics initiates late-stage milademetan cancer trial
- Rain Therapeutics up ~6% as director buys 587,002 shares
- Rain Therapeutics shares rise after Q1 results, cash position update
- Rain Therapeutics EPS misses by $0.23; issues guidance
| Date | Price | Open | High | Low | Vol | Change | ER | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 3 | 5.39 | 6.04 |
6.04
|
5.31
|
39.07K | -8.18% | ||||
| Mar 2 | 5.87 | 5.94 |
6.43
|
5.68
|
43.60K | 0.86% | ||||
| Mar 1 | 5.82 | 6.01 |
6.31
|
5.75
|
56.98K | -2.68% | ||||
| Feb 28 | 5.98 | 6.16 |
6.22
|
5.79
|
48.66K | -5.68% | ||||
| Feb 25 | 6.34 | 6.36 |
6.43
|
6.09
|
31.17K | 0.32% | ||||
| Feb 24 | 6.32 | 5.42 |
6.37
|
5.42
|
36.30K | 9.72% | ||||
| Feb 23 | 5.76 | 6.40 |
6.40
|
5.68
|
35.48K | -8.28% | ||||
| Feb 22 | 6.28 | 6.69 |
6.74
|
6.10
|
57.76K | -7.37% | ||||
| Feb 18 | 6.78 | 6.91 |
7.60
|
6.68
|
50.50K | -3% | ||||
| Feb 17 | 6.99 | 7.47 |
7.55
|
6.93
|
35.62K | -9.69% | ||||
| Feb 16 | 7.74 | 7.54 |
7.86
|
7.32
|
41.17K | 2.38% | ||||
| Feb 15 | 7.56 | 7.46 |
7.65
|
7.33
|
20.81K | 4.56% | ||||
| Feb 14 | 7.23 | 7.40 |
7.60
|
6.97
|
40.56K | -3.47% | ||||
| Feb 11 | 7.49 | 7.62 |
7.97
|
7.32
|
36.65K | -0.79% | ||||
| Feb 10 | 7.55 | 7.40 |
8.17
|
7.22
|
48.06K | -0.92% | ||||
| Feb 9 | 7.62 | 7.76 |
7.87
|
7.52
|
46.46K | 0.93% | ||||
| Feb 8 | 7.55 | 7.55 |
7.56
|
7.20
|
46.16K | -1.56% | ||||
| Feb 7 | 7.67 | 7.75 |
7.79
|
7.50
|
32.61K | -1.29% | ||||
| Feb 4 | 7.77 | 7.85 |
8.09
|
7.55
|
40.56K | -1.65% | ||||